Consumer Health COVID19

China monitors coronavirus mutations to adjust COVID-19 response

"It is a worry," said CNN, citing William Schaffner, professor at the Division of Infectious Diseases of Vanderbilt University Medical Cente...

 January 02, 2023 | News

Grand Pharma Announces Successful Clinical Progress of its Oral 3CL Protease Inhibitor GS221 Against COVID-19

GS221 has conducted 3 clinical trials. Current results of clinical trials show favorable safety and tolerance in the subjects. After administra...

 January 02, 2023 | News

Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates

The dose-confirming trial will evaluate the safety and effectiveness (immunogenicity) of different formulations of the CIC and influenza vaccine candidates...

 January 02, 2023 | News

China to downgrade COVID-19 management to Class B

In a statement released late Monday, the National Health Commission (NHC) renamed the Chinese term for COVID-19 from "novel coronavirus pneumonia" to "nove...

 December 28, 2022 | News

China Covid19 Surge : Coronavirus Pandemic Country Profile

What is important to note about these case figures? The reported case figures on a given date do not necessarily show the number of new cases on that da...

 December 22, 2022 | News

Pictor announces important COVID-19 trial to map immunity profile of New Zealanders

Pictor, a global leader in immunodiagnostics, today announced an important research project – the Pictor Antibody Clinical Trial (PACT-19) – wh...

 December 22, 2022 | News

Everest Medicines Announces New mRNA Rabies Vaccine Program and Achievement of Preclinical Proof-of-Concept Milestone

Rabies program, as the first non-COVID19 vaccine developed with a specialized mRNA platform, highlights Everest's discovery capabilities Clinically valida...

 December 15, 2022 | News

Ascletis Announces Positive Phase I Clinical Results of Oral RdRp Inhibitor ASC10 for COVID-19

Based on Ascletis' Phase I results of ASC10 and molnupiravir's clinical efficacy data in American, Japanese and Chinese patients, 800 mg twice daily of ASC...

 December 13, 2022 | News

China further optimizes COVID-19 response with new measures

Local authorities across China have soon made specific policies to implement the 10 new prevention and control measures recently rolled out by th...

 December 12, 2022 | News

Pictor announces funding round after successful launch in New Zealand and US of SARS-CoV-2 Antibody Test

 Pictor, a global leader in immunodiagnostics,  announced a funding round to help accelerate pipeline product development projects along with mar...

 December 05, 2022 | News

YS Biopharma Announces US FDA Clearance Of IND Application For PIKA COVID-19 vaccine

PIKA COVID-19 vaccine is composed of PIKA adjuvant and a stable trimeric form of the recombinant SARS-CoV-2 spike (S) protein as the main antigen component...

 November 11, 2022 | News

Merck Highlights New Data for Evobrutinib

Phase II clinical trial data of evobrutinib demonstrated low disease activity and stable EDSS, with NfL levels, a marker of neuronal injury, remaining lo...

 October 26, 2022 | News

SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines

  CEPI supports up to 40 mil. USD for early development of mRNA vaccine platform to SK bioscience; up to a further 100 mil. could be made available...

 October 26, 2022 | News

U.S. FDA Grants EUA for Novavax COVID-19 Vaccine, Adjuvanted as a Booster for Adults

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...

 October 24, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in